Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Current Liabilities (2019 - 2025)

Legend Biotech filings provide 7 years of Total Current Liabilities readings, the most recent being $636.4 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 129.17% to $636.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $636.4 million, a 129.17% increase, with the full-year FY2025 number at $636.4 million, up 129.17% from a year prior.
  • Total Current Liabilities hit $636.4 million in Q4 2025 for Legend Biotech, up from $433.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $636.4 million in Q4 2025 to a low of $145942.0 in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $255.4 million (2021), compared with a mean of $265.7 million.
  • Biggest five-year swings in Total Current Liabilities: surged 226883.16% in 2021 and later dropped 27.32% in 2023.
  • Legend Biotech's Total Current Liabilities stood at $229.2 million in 2021, then rose by 29.92% to $297.8 million in 2022, then fell by 27.32% to $216.4 million in 2023, then grew by 28.32% to $277.7 million in 2024, then surged by 129.17% to $636.4 million in 2025.
  • The last three reported values for Total Current Liabilities were $636.4 million (Q4 2025), $433.6 million (Q3 2025), and $265.5 million (Q2 2025) per Business Quant data.